These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36096184)

  • 21. The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice.
    Miguel DC; Ferraz ML; Alves Rde O; Yokoyama-Yasunaka JK; Torrecilhas AC; Romanha AJ; Uliana SR
    Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):945-8. PubMed ID: 21120371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
    Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
    Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
    Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi.
    Martins HR; Silva RM; Valadares HM; Toledo MJ; Veloso VM; Vitelli-Avelar DM; Carneiro CM; Machado-Coelho GL; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3282-9. PubMed ID: 17638698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
    García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
    Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
    Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge.
    Martín-Escolano J; Medina-Carmona E; Martín-Escolano R
    ACS Infect Dis; 2020 Nov; 6(11):2830-2843. PubMed ID: 33034192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A flow cytometer-based method to simultaneously assess activity and selectivity of compounds against the intracellular forms of Trypanosoma cruzi.
    Miranda CG; Solana ME; Curto MLA; Lammel EM; Schijman AG; Alba Soto CD
    Acta Trop; 2015 Dec; 152():8-16. PubMed ID: 26272680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.
    Moreno M; D'ávila DA; Silva MN; Galvão LM; Macedo AM; Chiari E; Gontijo ED; Zingales B
    Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):918-24. PubMed ID: 21120364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug discovery for chagas disease: A viewpoint.
    Kratz JM
    Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia.
    Díaz ML; Leal S; Mantilla JC; Molina-Berríos A; López-Muñoz R; Solari A; Escobar P; González Rugeles CI
    Parasit Vectors; 2015 Nov; 8():608. PubMed ID: 26612724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.
    Timm BL; da Silva PB; Batista MM; da Silva FH; da Silva CF; Tidwell RR; Patrick DA; Jones SK; Bakunov SA; Bakunova SM; Soeiro Mde N
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3720-6. PubMed ID: 24752263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
    Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.